Literature DB >> 6620166

Computation of model-independent pharmacokinetic parameters during multiple dosing.

L A Bauer, M Gibaldi.   

Abstract

Mesh:

Substances:

Year:  1983        PMID: 6620166     DOI: 10.1002/jps.2600720843

Source DB:  PubMed          Journal:  J Pharm Sci        ISSN: 0022-3549            Impact factor:   3.534


× No keyword cloud information.
  21 in total

1.  Simple methods for estimation of mean residence time and steady-state volume of distribution from continuous-infusion data.

Authors:  W R Gillespie
Journal:  Pharm Res       Date:  1991-02       Impact factor: 4.200

2.  Effect of Chronic Therapy on Absorption and Disposition of Cyclosporine.

Authors:  K Habucky; R Venkataramanan; R J Ptachcinski; G J Burckart; S Todo; T E Starzl
Journal:  Transplant Proc       Date:  1988-02       Impact factor: 1.066

3.  Effects of first-pass metabolism on metabolite mean residence time determination after oral administration of parent drug.

Authors:  K K Chan; M Gibaldi
Journal:  Pharm Res       Date:  1990-01       Impact factor: 4.200

4.  Pharmacokinetics of dapsone administered daily and weekly in human immunodeficiency virus-infected children.

Authors:  M Mirochnick; E Cooper; K McIntosh; J Xu; J Lindsey; D Jacobus; L Mofenson; J L Sullivan; W Dankner; L M Frenkel; S Nachman; D W Wara; D Johnson; V R Bonagura; M H Rathore; C K Cunningham; J McNamara
Journal:  Antimicrob Agents Chemother       Date:  1999-11       Impact factor: 5.191

5.  Cytochrome P450 mRNA expression in peripheral blood lymphocytes as a predictor of enzyme induction.

Authors:  Curtis E Haas; Daniel Brazeau; Denise Cloen; Brent M Booker; Valerie Frerichs; Colleen Zaranek; Reginald F Frye; Thomas Kufel
Journal:  Eur J Clin Pharmacol       Date:  2005-07-22       Impact factor: 2.953

6.  Pharmacokinetics of cefetamet (Ro 15-8074) and cefetamet pivoxil (Ro 15-8075) after intravenous and oral doses in humans.

Authors:  J R Koup; U C Dubach; R Brandt; R Wyss; K Stoeckel
Journal:  Antimicrob Agents Chemother       Date:  1988-04       Impact factor: 5.191

7.  Pharmacokinetics of cefonicid in patients with skin and skin structure infections.

Authors:  K L Heim-Duthoy; G L Peltier; D R Guay; G R Matzke
Journal:  Antimicrob Agents Chemother       Date:  1988-04       Impact factor: 5.191

8.  Pharmacokinetics of cefepime in patients with respiratory tract infections.

Authors:  J M Kovarik; J C ter Maaten; C M Rademaker; M Deenstra; I M Hoepelman; H C Hart; G R Matzke; J Verhoef
Journal:  Antimicrob Agents Chemother       Date:  1990-10       Impact factor: 5.191

9.  Impaired clearance of ceftizoxime and cefotaxime after orthotopic liver transplantation.

Authors:  G J Burckart; R J Ptachcinski; D H Jones; D L Howrie; R Venkataramanan; T E Starzl
Journal:  Antimicrob Agents Chemother       Date:  1987-02       Impact factor: 5.191

10.  Pharmacokinetics of oral fleroxacin in male and premenopausal female volunteers.

Authors:  J S Bertino; A N Nafziger
Journal:  Antimicrob Agents Chemother       Date:  1996-03       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.